References
- Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48(4):526–535.
- Rutter MD, Saunders BP, Wilkinson KH, et al., Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut. 2004;53(12):1813–1816. .
- Selinger CP, Andrews JM, Titman A, et al. Long-term follow up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2014 Apr;12(4):644–650.
- Cairns SR, Scholefield JH, Steele RJ, et al., Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59(5):666–689. .
- Ekkelenkamp VE, Dowler K, Valori RM, et al. Patient comfort and quality in colonoscopy. World J Gastroenterol. 2013;19(15):2355–2361.
- Lee TJ, Nickerson C, Goddard AF, et al. Outcome of 12-month surveillance colonoscopy in high-risk patients in the National health service bowel cancer screening programme. Colorectal Dis. 2013;15(8):e435–442.
- Zhen Y, Luo C, Zhang H. Early detection of ulcerative colitis-associated colorectal cancer. Gastroenterol Rep (Oxf). 2018;6(2):83–92.
- Klepp P, Kisiel JB, Smastuen MC, et al. Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study. Scand J Gastroenterol. 2018;53(3):273–278.
- Kisiel JB, Yab TC, Nazer Hussain FT, et al. Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;37(5):546–554. .
- Ahmed FE, Jeffries CD, Vos PW, et al. Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue. Cancer Genomics Proteomics. 2009;6(5):281–295.
- Friedman S, Cheifetz AS, Farraye FA, et al. High self-efficacy predicts adherence to surveillance colonoscopy in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20(9):1602–1610. .
- Naumann DN, Potter-Concannon S, Karandikar S. Interobserver variability in comfort scores for screening colonoscopy. Frontline Gastroenterol. 2019;10(4):372–378.
- Falt P, Smajstrla V, Fojtik P, et al. Water-aided colonoscopy in inflammatory bowel disease patients-a randomised, single-centre trial. J Crohns Colitis. 2015;9(9):720–724.
- Goodsall TM, Noy R, Nguyen TM, et al. Systematic review: patient perceptions of monitoring tools in inflammatory bowel disease. J Can Assoc Gastroenterol. 2020. DOI:10.1093/jcag/gwaa001.
- Ryhlander J, Ringstrom G, Simren M, et al. Undergoing repeated colonoscopies - experiences from patients with inflammatory bowel disease. Scand J Gastroenterol. 2019;54(12):1467–1472.
- Noiseux I, Veilleux S, Bitton A, et al. Inflammatory bowel disease patient perceptions of diagnostic and monitoring tests and procedures. BMC Gastroenterol. 2019;19(1):30.
- Aboumarzouk OM, Agarwal T, Syed Nong Chek SA, et al. Nitrous oxide for colonoscopy. Cochrane Database Syst Rev. 2011;8:CD008506.
- Lamb CA, Kennedy NA, Raine T, et al. British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019 Dec; 68(Suppl 3):s1–s106.
- Denters MJ, Schreuder M, Depla ACTM, et al. Patients’ perception of colonoscopy: patients with inflammatory bowel disease and irritable bowel syndrome experience the largest burden. Eur J Gastroenterol Hepatol. 2013;25(8):964–972.